Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcitabine and Cisplatin Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01121393
What this trial is testing

BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma
Boehringer Ingelheim 364
Testing effectiveness (Phase 2)Study completedNCT00003202
What this trial is testing

Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 40
Not applicableUnknownNCT02344979
What this trial is testing

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

Who this might be right for
Thrombocytopenia
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351
What this trial is testing

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
University of Washington 33
Large-scale testing (Phase 3)Study completedNCT00064077
What this trial is testing

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
Gynecologic Oncology Group 513
Large-scale testing (Phase 3)UnknownNCT05822934
What this trial is testing

Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer

Who this might be right for
Urinary Bladder Cancer
Assiut University 20
Post-approval studies (Phase 4)UnknownNCT03071822
What this trial is testing

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

Who this might be right for
Peripheral T Cell Lymphoma
The University of Hong Kong 50
Large-scale testing (Phase 3)Ended earlyNCT02082522
What this trial is testing

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Who this might be right for
Hilar Cholangiocarcinoma
Concordia Laboratories Inc. 28
Large-scale testing (Phase 3)Looking for participantsNCT06156514
What this trial is testing

Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer

Who this might be right for
Locally Advanced Cervical CancerGemcitabineChemo-radiotherapy
National Institute of Cancerología 140
Large-scale testing (Phase 3)Ended earlyNCT03656536
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Unresectable CholangiocarcinomaMetastatic Cholangiocarcinoma
Incyte Corporation 167
Large-scale testing (Phase 3)UnknownNCT05189028
What this trial is testing

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

Who this might be right for
Cervical CancerNeoadjuvant Chemotherapy
Chuangzhen Chen 290
Not applicableTemporarily Not AvailableNCT01297101
What this trial is testing

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Chest Hospital
Testing effectiveness (Phase 2)Ended earlyNCT00714948
What this trial is testing

Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Bladder CancerURINARY BLADDER
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Looking for participantsNCT07030140
What this trial is testing

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHilar CholangiocarcinomaBile Duct Cancer
Jinbo Yue 38
Large-scale testing (Phase 3)Ended earlyNCT00470340
What this trial is testing

Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients

Who this might be right for
Liver NeoplasmsLiver CirrhosisCarcinoma, Hepatocellular+2 more
Assistance Publique - Hôpitaux de Paris 263
Testing effectiveness (Phase 2)Study completedNCT00027703
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 106
Early research (Phase 1)Study completedNCT04361409
What this trial is testing

Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Carcinoma
China Medical University Hospital 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06567600
What this trial is testing

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy EffectImmunotherapy
Third Affiliated Hospital, Sun Yat-Sen University 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06927128
What this trial is testing

Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma

Who this might be right for
UTUCNAC
Changhai Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00003037
What this trial is testing

Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Next Page